Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | +0.80% | -4.55% | -29.21% |
Mar. 14 | Transcript : Protalix BioTherapeutics, Inc., 2023 Earnings Call, Mar 14, 2024 | |
Mar. 14 | Protalix BioTherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Protalix BioTherapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Protalix BioTherapeutics, Inc.
HC Wainwright |
EPS Revisions
- Stock
- Equities
- Stock Protalix BioTherapeutics, Inc. - Nyse
- Consensus Protalix BioTherapeutics, Inc.